Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin and 5-fluorouracil against epirubicin, cisplatin and 5-fluorouracil
Completed
- Conditions
- Gastric cancerCancer
- Registration Number
- ISRCTN83369741
- Lead Sponsor
- Tehran University of Medical Sciences (Iran)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
Patients with histologically confirmed advanced gastric cancer
Exclusion Criteria
Patients with local or local- regional gastric cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Quality of life and survival